C. Richard Boland spends much of his time researching Colorectal cancer, Microsatellite instability, Cancer research, Internal medicine and Cancer. He combines subjects such as Surgery, Allele, Family medicine and Pathology with his study of Colorectal cancer. The study incorporates disciplines such as High-Frequency Microsatellite Instability, DNA mismatch repair and CpG Island Methylator Phenotype in addition to Microsatellite instability.
His work deals with themes such as DNA methylation, Immunology, Genome instability, Loss of heterozygosity and PTEN, which intersect with Cancer research. His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Oncology. His Cancer research focuses on microRNA and how it relates to Epithelial–mesenchymal transition, Vimentin and ETS1.
C. Richard Boland mostly deals with Colorectal cancer, Internal medicine, Cancer research, Microsatellite instability and Cancer. His research integrates issues of Carcinogenesis, microRNA, Bioinformatics and Pathology in his study of Colorectal cancer. In his study, which falls under the umbrella issue of Internal medicine, Metastasis is strongly linked to Oncology.
His Cancer research study incorporates themes from Cell culture, DNA methylation, Genome instability, Microsatellite and Epigenetics. His DNA methylation research is multidisciplinary, incorporating elements of Tumor suppressor gene and Methylation. C. Richard Boland has researched Microsatellite instability in several fields, including MLH1, Lynch syndrome, DNA mismatch repair, Molecular biology and Loss of heterozygosity.
C. Richard Boland spends much of his time researching Colorectal cancer, Internal medicine, Oncology, Cancer and Lynch syndrome. His research in Colorectal cancer intersects with topics in Cancer research, microRNA, MEDLINE and Pathology. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Methylation and Bioinformatics.
C. Richard Boland focuses mostly in the field of Oncology, narrowing it down to topics relating to Cohort and, in certain cases, Circulating MicroRNA. His Lynch syndrome research includes themes of Germline mutation, PMS2, MSH2 and Microsatellite instability. His work carried out in the field of Microsatellite instability brings together such families of science as KRAS, Endometrial cancer, Frameshift mutation and Loss of heterozygosity.
His main research concerns Colorectal cancer, Colonoscopy, Internal medicine, Lynch syndrome and MEDLINE. In general Colorectal cancer, his work in Familial Colorectal Cancer Type X is often linked to Task force linking many areas of study. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology.
His Lynch syndrome research incorporates elements of Microsatellite instability and Genetic testing. His Pathology research includes elements of Hematopathology and Frameshift mutation. The concepts of his Bioinformatics study are interwoven with issues in Germline mutation and Cancer research, Angiogenesis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: Development of International Criteria for the Determination of Microsatellite Instability in Colorectal Cancer
C. Richard Boland;Stephen N. Thibodeau;Stanley R. Hamilton;David Sidransky.
Cancer Research (1998)
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Asad Umar;C. Richard Boland;Jonathan P. Terdiman;Sapna Syngal.
Journal of the National Cancer Institute (2004)
Microsatellite Instability in Colorectal Cancer
C. Richard Boland;Ajay Goel.
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review
Henry T. Lynch;Thomas C. Smyrk;Patrice Watson;Stephen J. Lanspa.
Our new president—Jon I. Isenberg, M.D
C.Richard Boland;Tadataka Yamada.
Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer
Francis M. Giardiello;John I. Allen;Jennifer E. Axilbund;C. Richard Boland.
Loss of DNA mismatch repair in acquired resistance to cisplatin.
S Aebi;B Kurdi-Haidar;R Gordon;B Cenni.
Cancer Research (1996)
Hereditary Nonpolyposis Colorectal Cancer: the Syndrome, the Genes, and Historical Perspectives
Giancarlo Marra;C R Boland.
Journal of the National Cancer Institute (1995)
Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer.
Douglas K. Rex;C. Richard Boland;Jason A. Dominitz;Francis M. Giardiello.
Gastrointestinal Endoscopy (2017)
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis
Keun Hur;Yuji Toiyama;Masanobu Takahashi;Francesc Balaguer.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: